http://xh.ccbcht.com
Home > Imveliso > I-Varicella Vaccine (Live) > Iimveliso ezigqityiweyo > Chicken Pox Vaccine Finished Products Live

Chicken Pox Vaccine Finished Products Live

Ulwazi oluSiseko

Umzekelo No.: 0.5ml/vial

Ingcaciso yeMveliso

Varicella vaccine is 70% to 90% effective for preventing varicella and more than 95% effective for preventing severe varicella. Follow-up evaluations have taken place in the United States of children immunized that revealed protection for at least 11 years. Also, studies were conducted in Japan which indicated protection for at least 20 years.

People who do not develop enough protection when they get the vaccine may develop a mild case of the disease when in close contact with a person with chickenpox. In these cases, people show very little sign of illness. This has been the case of children who get the vaccine in their early childhood and later have contact with children with chickenpox. Some of these children may develop a mild chickenpox also known as breakthrough disease.

Another vaccine, known as zoster vaccine, is simply a larger-than-normal dose of the same vaccine used against chickenpox, and is used in older adults to reduce the risk of shingles (also called herpes zoster) and postherpetic neuralgia, which are caused by the same virus.

388503295195126476


Iikhathalo zomkhiqizo : I-Varicella Vaccine (Live) > Iimveliso ezigqityiweyo

I-imeyili kule mthengisi
  • *Isihloko:
  • *Imiyalezo:
    Umyalezo wakho kufuneka ube phakathi kweenhlamvu ezingama-20-8000
Ukunxibelelana noMthengisi?Umthengisi
Alice Zhang Ms. Alice Zhang
Ndingakwenzela ntoni?
Qhagamshelana noMthengisi